TrialJournal of diabetes science and technology2011

The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.

Thomas Schöndorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.